Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions

Sponsor
Meir Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04219605
Collaborator
(none)
200
1
24
8.3

Study Details

Study Description

Brief Summary

Evaluate the diagnostic performance of the Gyni™ device to detect different vaginitis conditions by comparison to microscopic diagnosis and related lab tests.

Detailed Description

During gynecological exams, vaginal discharge samples will be are taken for testing the pH level, microscopic examination and laboratory examinations (vaginal cultures and sexually transmitted infections).

One additional sample will be taken intended for the Gyni™ system diagnosis. This additional examination will be performed in the clinic by pulling the cytobrush through a dedicated cartridge and scanning it in the Gyni table-top scanner. The result diagnosis will be anonymously kept in the cloud.

The diagnosis suggested by the Gyni system will not be visible to the physician in order to prevent any bias. Results from the physician, from the device and from the lab will be summarized and compared by the chief investigator

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions
Actual Study Start Date :
Dec 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Symptomatic vaginitis patients

Symptomatic patients evaluated in the clinic for vulvovaginal symptoms.

Outcome Measures

Primary Outcome Measures

  1. Diagnostic performance [12 months]

    Specificity and sensitivity of the device performance in regard to vaginitis conditions

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women with vaginal complaints: Discharge, Malodor, Itching, Irritation, Dyspareunia, Pain

  • Age >= 18y

Exclusion Criteria:
  • Age < 18y

  • Not eligible to sign an informed consent

  • Vaginal discharge samples found microscopically not interpret-able by the investigator due to patient using vaginal creams, ointments, lubricants or sperm presence.

  • During menstruation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clalit HMO Jerusalem Israel

Sponsors and Collaborators

  • Meir Medical Center

Investigators

  • Principal Investigator: Avraham Ben Chetrit, MD, Clalit HMO

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT04219605
Other Study ID Numbers:
  • 0120-19-COM1
First Posted:
Jan 7, 2020
Last Update Posted:
Apr 12, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 12, 2022